Valigen to Apply Third Wave Agbio Technology to Genetically Modified Plants | GenomeWeb

NEW YORK, July 18 – Third Wave Agbio said Wednesday that Valigen has agreed to use its Invader SNP analysis platform to study genetic variations in plants.

As part of its research into developing agricultural products with improved traits, Valigen, headquartered in Paris-la-Defense, France, will use Third Wave Agbio’s technology to detect genetic changes in plants modified using Valigen’s Genoplasty technology. 

Financial details of the deal were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.